Eisai Co Stock Today

ESALF Stock  USD 28.86  1.64  5.38%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Eisai Co is trading at 28.86 as of the 16th of March 2025. This is a 5.38 percent decrease since the beginning of the trading day. The stock's lowest day price was 28.86. Eisai Co has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company has 286.7 M outstanding shares. More on Eisai Co

Moving against Eisai Pink Sheet

  0.63TEVA Teva Pharma IndustriesPairCorr
  0.58CHHE China Health IndustriesPairCorr
  0.41GSTX Graphene Solar TechnPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Eisai Pink Sheet Highlights

CEOGary Hendler
Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Eisai Co [ESALF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Large-Cap' category with a current market capitalization of 16.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eisai Co's market, we take the total number of its shares issued and multiply it by Eisai Co's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eisai Co classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 286.7 M outstanding shares. Eisai Co has accumulated about 290.45 B in cash with 117.59 B of positive cash flow from operations.
Check Eisai Co Probability Of Bankruptcy
Ownership Allocation
Eisai Co holds a total of 286.7 Million outstanding shares. 30% of Eisai Co outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Eisai Ownership Details

Eisai Co Risk Profiles

Eisai Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eisai Co without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stocks Directory Now

   

Stocks Directory

Find actively traded stocks across global markets
All  Next Launch Module

Other Information on Investing in Eisai Pink Sheet

Eisai Co financial ratios help investors to determine whether Eisai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai Co security.